These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2260915)

  • 1. Effect of estrogens on prolactin secretion in transsexual subjects.
    Goh HH; Ratnam SS
    Arch Sex Behav; 1990 Oct; 19(5):507-16. PubMed ID: 2260915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of ethinyl estradiol on semen quality and various hormonal parameters in a eugonadal male.
    Lübbert H; Leo-Rossberg I; Hammerstein J
    Fertil Steril; 1992 Sep; 58(3):603-8. PubMed ID: 1387850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The neuroendocrine response of luteinizing hormone to estrogen administration in the human is not sex specific but dependent on the hormonal environment.
    Gooren L
    J Clin Endocrinol Metab; 1986 Sep; 63(3):589-93. PubMed ID: 3734031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of sex steroids on plasma total homocysteine levels: a study in transsexual males and females.
    Giltay EJ; Hoogeveen EK; Elbers JM; Gooren LJ; Asscheman H; Stehouwer CD
    J Clin Endocrinol Metab; 1998 Feb; 83(2):550-3. PubMed ID: 9467573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of estrogens, clomiphene and castration in a male transsexual with as compared to those without hypersecretion of gonadotropins.
    Goh HH; Ratnam SS
    Gynecol Endocrinol; 1990 Jun; 4(2):127-41. PubMed ID: 2118708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of pretreatment plasma levels of estradiol and sex-hormone-binding globulin-binding capacity with clinical stage and survival of patients with prostatic cancer.
    Haapiainen R; Rannikko S; Adlercreutz H; Alfthan O
    Prostate; 1986; 8(2):127-37. PubMed ID: 3952023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of large doses of estrogen on prolactin and growth hormone release.
    Ehara Y; Siler TM; Yen SS
    Am J Obstet Gynecol; 1976 Jun; 125(4):455-8. PubMed ID: 984083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen replacement therapy after the menopause. Estrogenicity and metabolic effects.
    Helgason S
    Acta Obstet Gynecol Scand Suppl; 1982; 107():1-29. PubMed ID: 6282033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of transdermal testosterone or oral dydrogesterone on hypoactive sexual desire disorder in transsexual women: results of a pilot study.
    Kronawitter D; Gooren LJ; Zollver H; Oppelt PG; Beckmann MW; Dittrich R; Mueller A
    Eur J Endocrinol; 2009 Aug; 161(2):363-8. PubMed ID: 19497984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute and chronic estrogen effects upon serum somatomedin activity, growth hormone, and prolactin in man.
    Wiedemann E; Schwartz E; Frantz AG
    J Clin Endocrinol Metab; 1976 May; 42(5):942-52. PubMed ID: 178687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma hormone levels in women receiving new oral contraceptives containing ethinyl estradiol plus levonorgestrel or desogestrel.
    Gaspard UJ; Romus MA; Gillain D; Duvivier J; Demey-Ponsart E; Franchimont P
    Contraception; 1983 Jun; 27(6):577-90. PubMed ID: 6225622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacodynamic effects of ethinyl estradiol in women using vaginal devices releasing small doses of levonorgestrel at a constant rate.
    Toddyvalla V; Johannisson E; Landgren BM; Cekan SZ; Diczfalusy E
    Contraception; 1983 Jul; 28(1):21-39. PubMed ID: 6414759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of hepatic impact of oral and vaginal administration of ethinyl estradiol.
    Goebelsmann U; Mashchak CA; Mishell DR
    Am J Obstet Gynecol; 1985 Apr; 151(7):868-77. PubMed ID: 3920910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen-induced prolactinoma in a man.
    Gooren LJ; Assies J; Asscheman H; de Slegte R; van Kessel H
    J Clin Endocrinol Metab; 1988 Feb; 66(2):444-6. PubMed ID: 3339116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of sex hormone-binding globulin secretion in human hepatoma G2 cells.
    Browne-Martin K; Longcope C
    Steroids; 2001 Aug; 66(8):605-7. PubMed ID: 11430992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential lipemic and proteinemic response to oral ethinyl estradiol and parenteral estradiol cypionate.
    Buckman MT; Johnson J; Ellis H; Srivastava L; Peake GT
    Metabolism; 1980 Sep; 29(9):803-5. PubMed ID: 7412555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of raloxifene on circulating prolactin and estradiol levels in premenopausal women at high risk for developing breast cancer.
    Faupel-Badger JM; Prindiville SA; Venzon D; Vonderhaar BK; Zujewski JA; Eng-Wong J
    Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1153-8. PubMed ID: 16775175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pituitary function and DHEA-S in male acne and DHEA-S, prolactin and cortisol before and after oral contraceptive treatment in female acne.
    Palatsi R; Reinilä M; Kivinén S
    Acta Derm Venereol; 1986; 66(3):225-30. PubMed ID: 2426899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pituitary and ovarian function in women receiving hormonal contraception.
    Cohen BL; Katz M
    Contraception; 1979 Nov; 20(5):475-87. PubMed ID: 393456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum pharmacokinetics of orally administered desogestrel and binding of contraceptive progestogens to sex hormone-binding globulin.
    Bergink W; Assendorp R; Kloosterboer L; van Lier W; Voortman G; Qvist I
    Am J Obstet Gynecol; 1990 Dec; 163(6 Pt 2):2132-7. PubMed ID: 2147817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.